HCW Biologics Inc [NASDAQ: HCWB] gained 60.82% or 2.1 points to close at $5.55 with a heavy trading volume of 87476272 shares.
It opened the trading session at $5.46, the shares rose to $7.35 and dropped to $4.9, the range by which the price of stock traded the whole day. The daily chart for HCWB points out that the company has recorded -62.99% loss over the past six months.
If we look at the average trading volume of 132.34K shares, HCWB reached to a volume of 87476272 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about HCW Biologics Inc [HCWB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HCWB shares is $35.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HCWB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Trading performance analysis for HCWB stock
HCW Biologics Inc [HCWB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 38.06. With this latest performance, HCWB shares gained by 30.28% in over the last four-week period, additionally sinking by -62.99% over the last 6 months – not to mention a drop of -68.90% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HCWB stock in for the last two-week period is set at 66.66, with the RSI for the last a single of trading hit 0.77, and the three-weeks RSI is set at 0.60 for HCW Biologics Inc [HCWB]. The present Moving Average for the last 50 days of trading for this stock 4.37, while it was recorded at 3.85 for the last single week of trading, and 11.24 for the last 200 days.
HCW Biologics Inc [HCWB]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and HCW Biologics Inc [HCWB] shares currently have an operating margin of -1534.31% and a Gross Margin at -162.73%. HCW Biologics Inc’s Net Margin is presently recorded at -2588.00%.
HCW Biologics Inc (HCWB) Capital Structure & Debt Analysis
According to recent financial data for HCW Biologics Inc. ( HCWB), the Return on Equity (ROE) stands at -27725.80%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -77.35%, reflecting the company’s efficiency in generating profits from its assets. Additionally, HCW Biologics Inc’s Return on Invested Capital (ROIC) is -1044.52%, showcasing its effectiveness in deploying capital for earnings.
HCW Biologics Inc (HCWB) Efficiency & Liquidity Metrics
HCW Biologics Inc (HCWB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, HCW Biologics Inc. (HCWB) effectively leverages its workforce, generating an average of -$598611.11 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.11% and a Quick Ratio of 0.11%, indicating strong ability to cover short-term liabilities.
HCW Biologics Inc [HCWB]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, HCW Biologics Inc posted -4/share EPS, while the average EPS was predicted by analysts to be reported at -5.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.2. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HCWB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for HCW Biologics Inc go to 55.47%.
An analysis of Institutional ownership at HCW Biologics Inc [HCWB]
There are presently around $1.00%, or 1.38%% of HCWB stock, in the hands of institutional investors. The top three institutional holders of HCWB stocks are: AVANTAX PLANNING PARTNERS, INC. with ownership of 0.28 million shares, which is approximately 0.751%. HIGHTOWER ADVISORS, LLC, holding 0.18 million shares of the stock with an approximate value of $$0.12 million in HCWB stocks shares; and HIGHTOWER ADVISORS, LLC, currently with $$0.11 million in HCWB stock with ownership which is approximately 0.4577%.
